Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Clinical trial NCT00550420 · TERMINATED

Trial details

NCT number: NCT00550420
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2007-10-01
Primary completion: 2009-02-12
Enrollment: 331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.